Osteosarcoma of the pelvis in children and young adults: The St. Jude Children's Research Hospital experience

Cancer

Volumn 103, Issue 7, 2005, Pages 1468-1474

  Saab, Raya ^a,b   Rao, Bhaskar N ^a,b   Rodriguez Galindo, Carlos ^a,b   Billups, Catherine A ^a   Fortenberry, Tamra N ^a   Daw, Najat C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Hemipelvectomy; Ilium; Osteosarcoma; Outcome; Pubis; Sacrum; Treatment

Indexed keywords

ADOLESCENT; ADULT; BONE DISEASE; CANCER GRADING; CANCER PATIENT; CANCER SURGERY; CHILD; EXPERIENCE; FEMALE; HEMIPELVECTOMY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OUTCOMES RESEARCH; PELVIS TUMOR; PRIORITY JOURNAL; RESEARCH; REVIEW; SACRUM; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; OSTEOSARCOMA; PELVIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 15744369245     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20959     Document Type: Review

References (27)

1. Huvos A. Bone tumors: diagnosis, treatment, and prognosis, 2 ed. Philadelphia: WB Saunders Company, 1991.
2. Bentzen SM, Poulsen HS, Kaae S, et al. Prognostic factors in osteosarcomas. A regression analysis. Cancer. 1988;62:194-202.
3. Ham SJ, Kroon HM, Koops HS, Hoekstra HJ. Osteosarcoma of the pelvis-oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol. 2000;26:53-60.
4. Fahey M, Spanier SS, Vander Griend RA. Osteosarcoma of the pelvis. A clinical and histopathological study of twenty-five patients. J Bone Joint Surg Am. 1992;74:321-330.
5. Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44:973-989.
6. Grimer RJ, Carter SR, Tillman RM, Spooner D, Mangham DC, Kabukcuoglu Y. Osteosarcoma of the pelvis. J Bone Joint Surg Br. 1999;81:796-802.
7. Kawai A, Huvos AG, Meyers PA, Healey JH. Osteosarcoma of the pelvis. Oncologic results of 40 patients. Clin Orthop. 1998;196-207.
8. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade Osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2002;20:776-790.
9. Marangolo M, Tienghi A, Fiorentini G, et al. Treatment of pelvic osteosarcoma. Ann Oncol. 1992;3(Suppl 2):S19-S21.
10. Wolf RE. Sarcoma and metastatic carcinoma. J Surg Oncol. 2000;73:39-46.
11. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101:14-18.
12. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49: 1221-1230.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: analysis and examples. Br J Cancer. 1977;35:1-39.
15. Bielack SS, Wulff B, Delling G, et al. Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma Study Group (COSS). Med Pediatr Oncol. 1995;24:6-12.
16. Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334-341.
17. Kawai A, Healey JH, Boland PJ, Lin PP, Huvos AG, Meyers PA. Prognostic factors for patients with sarcomas of the pelvic bones. Cancer. 1998;82:851-859.
18. Spiegel DA, Richardson WJ, Scully SP, Harrelson JM. Long-term survival following total sacrectomy with reconstruction for the treatment of primary osteosarcoma of the sacrum. A case report. J Bone Joint Surg Am. 1999;81:848-855.
19. Avradopoulos KA, Vezeridis MP, Wanebo HJ. Pelvic exenteration for recurrent rectal cancer. Adv Surg. 1996;29:215-233.
20. Bieling P, Rehan N, Winkler P, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996;14:848-858.
21. Wurtz LD, Peabody TD, Simon MA. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis. J Bone Joint Surg Am. 1999;81:317-325.
22. Estrada-Aguilar J, Greenberg H, Walling A, et al. Primary treatment of pelvic osteosarcoma. Report of five cases. Cancer. 1992;69:1137-1145.
23. Huvos AG, Woodard HQ, Cahan WG, et al. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer. 1985;55:1244-1255.
24. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol. 1999;17:1164.
25. Carrie C, Breteau N, Negrier S, et al. The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary report. Med Pediatr Oncol. 1994;22:355-357.
26. Anderson PM, Wiseman GA, Dispenzieri A, et al. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol. 2002;20: 189-196.
27. Bruland OS, Skretting A, Solheim OP, Aas M. Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. Acta Oncol. 1996;35:381-384.